TCL Archive ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals September 20, 2013
TCL Archive NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive March 23, 1984